Insulet (PODD)
(Delayed Data from NSDQ)
$166.19 USD
+2.02 (1.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $166.26 +0.07 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Insulet Corporation [PODD]
Reports for Purchase
Showing records 301 - 320 ( 340 total )
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Bucking Headwinds - Three Medical Device Companies To Ride Into The New Year
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Strong Q3 Rev Growth Negatively Affected By Production Problem - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Manufacturing Issues highlighted in Q3 shortfall All eyes on next-gen OmniPod clearance
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Respectable Q3 despite disruption, maintaining BUY but reducing PT to $18.60
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
The Truffle Shuffle-Diabetes Edition: Investment Implications of Obesity on Diabetes Devices
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-11; Banking on the next-gen OmniPod; Upgrading to Market Perform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Difficult as it is, we are downgrading the stock to an UnderPerform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Difficult as it is, we are downgrading the stock to an UnderPerform...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.